IS YOUR CDMO PROACTIVELY PLANNING TO MEET YOUR NEEDS?
The CDMO industry prides itself on its flexibility, adaptability, and responsiveness to changing customer needs. Helping drug developers address the challenges their programs may encounter, and adapting to their needs, is at the core of a successful CDMO business model.
- Consider the following:
- Can your CDMO be more flexible?
- Offer more adaptive solutions?
- Provide more responsive services?
- Can your CDMO get your life-saving treatments to the clinic faster?
In response to those questions and the changing demands of our customers, Ajinomoto Bio-Pharma Services established AJILITY™ platform.
THE AJILITY ADVANTAGE
The ability for clients to leverage Ajinomoto Bio-Pharma Services’
- extensive experience in drug product manufacturing
- technical knowledge
- regulatory support expertise
- highest of quality standards
is the greatest advatage to the AJILITY platform to expedite therapeutics to the clinic.
The AJILITY platform takes the burden off the client and allows them to partner with a CDMO that will prioritize these programs and drive them to completion.